Literature DB >> 3370076

[Immunologic in vivo and in vitro studies on Echinacea extracts].

V R Bauer1, K Jurcic, J Puhlmann, H Wagner.   

Abstract

Ethanolic extracts of Echinacea purpurea, E. pallida and E. angustifolia roots were examined for immunological activity in the carbon clearance test with mice and in the granulocyte test. In the in vivo experiment all extracts, administered orally, were found to enhance phagocytosis significantly. These results correlate with the stimulation of phagocytosis in the in vitro granulocyte test. The lipophilic fractions of the extracts appeared to be more active than the polar fractions. All extracts were analyzed by HPLC in order to correlate the chemical constituents with the immunological activities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370076

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  12 in total

Review 1.  A strategic call to utilize Echinacea-garlic in flu-cold seasons.

Authors:  T Abdullah
Journal:  J Natl Med Assoc       Date:  2000-01       Impact factor: 1.798

2.  Enrichment of Echinacea angustifolia with Bauer alkylamide 11 and Bauer ketone 23 increased anti-inflammatory potential through interference with cox-2 enzyme activity.

Authors:  Carlie A Lalone; Nan Huang; Ludmila Rizshsky; Man-Yu Yum; Navrozedeep Singh; Cathy Hauck; Basil J Nikolau; Eve S Wurtele; Marian L Kohut; Patricia A Murphy; Diane F Birt
Journal:  J Agric Food Chem       Date:  2010-08-11       Impact factor: 5.279

3.  Patterns of Variation in Alkamides and Cichoric Acid in Roots and Aboveground Parts of Echinacea purpurea (L.) Moench.

Authors:  Luping Qu; Ying Chen; Xiping Wang; Richard Scalzo; Jeanine M Davis
Journal:  HortScience       Date:  2005-08       Impact factor: 1.455

4.  Echinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of Bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in Caco-2 cells.

Authors:  Zhiyi Qiang; Cathy Hauck; Joe-Ann McCoy; Mark P Widrlechner; Manju B Reddy; Patricia A Murphy; Suzanne Hendrich
Journal:  Planta Med       Date:  2013-02-13       Impact factor: 3.352

5.  Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells.

Authors:  Carlie A LaLone; Kimberly D P Hammer; Lankun Wu; Jaehoon Bae; Norma Leyva; Yi Liu; Avery K S Solco; George A Kraus; Patricia A Murphy; Eve S Wurtele; Ok-Kyung Kim; Kwon Ii Seo; Mark P Widrlechner; Diane F Birt
Journal:  J Agric Food Chem       Date:  2007-08-15       Impact factor: 5.279

6.  Agrobacterium rhizogenes-mediated transformation of Echinacea purpurea.

Authors:  M Trypsteen; M Van Lijsebettens; R Van Severen; M Van Montagu
Journal:  Plant Cell Rep       Date:  1991-06       Impact factor: 4.570

7.  Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses.

Authors:  Shu-Yi Yin; Wen-Hsin Wang; Bi-Xue Wang; Kandan Aravindaram; Pei-Ing Hwang; Han-Ming Wu; Ning-Sun Yang
Journal:  BMC Genomics       Date:  2010-11-01       Impact factor: 3.969

8.  Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells.

Authors:  Chien-Yu Wang; Vanisree Staniforth; Ming-Tsang Chiao; Chia-Chung Hou; Han-Ming Wu; Kuo-Chen Yeh; Chun-Houh Chen; Pei-Ing Hwang; Tuan-Nan Wen; Lie-Fen Shyur; Ning-Sun Yang
Journal:  BMC Genomics       Date:  2008-10-13       Impact factor: 3.969

9.  Effects of Echinacea purpurea on Hepatic and Renal Toxicity Induced by Diethylnitrosamine in Rats.

Authors:  Annahita Rezaie; Ali Fazlara; Mojtaba Haghi Karamolah; Ali Shahriari; Hossein Najaf Zadeh; Marzieh Pashmforosh
Journal:  Jundishapur J Nat Pharm Prod       Date:  2013-05-04

Review 10.  Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review.

Authors:  Hannah Ayrle; Meike Mevissen; Martin Kaske; Heiko Nathues; Niels Gruetzner; Matthias Melzig; Michael Walkenhorst
Journal:  BMC Vet Res       Date:  2016-06-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.